Tung‐Hu Tsai

National Cheng Kung University Hospital — Taiwan

Medicine · Health Sciences

61h-index15.6kcitations468works2.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Antibiotics Pharmacokinetics and Efficacy(53), Drug Transport and Resistance Mechanisms(48), Pharmacological Effects of Natural Compounds(47), Traditional Chinese Medicine Analysis(29), Natural product bioactivities and synthesis(27)

Publications468 total

The impact of primary tumor location of colorectal cancer on the survival outcome of patients with brain metastasis: a systematic review and meta-analysis
European journal of medical research·2025Open Access
191. MITOCHONDRIAL DNA COPY NUMBER AS A MEDIATOR OF THE RELATIONSHIP BETWEEN INSULIN RESISTANCE AND COGNITIVE FUNCTION IN PATIENTS WITH EUTHYMIC BIPOLAR DISORDER
The International Journal of Neuropsychopharmacology·2025Open Access
Comparative survival outcome of synchronous and metachronous brain metastasis from colorectal cancer: A meta‑analysis
Oncology Letters·2025· 2 citedOpen Access
The anti-COVID-19 drug nirmatrelvir crosses the blood‒brain barrier and exhibits herb–drug pharmacokinetic interactions with Scutellaria baicalensis formulations
Heliyon·2024· 5 citedOpen Access
Cordycepin Augments the Efficacy of Anti-PD1 against Colon Cancer
Biomedicines·2024· 3 citedOpen Access
Multi-microdialysis analytical system to monitor acetaminophen and its pharmacokinetic interaction with A. bidentata in rat blood, forelimb extensor muscle, brain striatum, and the knee joint cavity
Journal of Pharmaceutical and Biomedical Analysis·2024
Pharmacokinetic analysis of antiviral drug ritonavir across the blood–brain barrier and its interaction with Scutellaria baicalensis using multisite microdialysis in rats
Journal of Pharmaceutical and Biomedical Analysis·2024· 3 cited
The clinical application of traditional Chinese medicine NRICM101 in hospitalized patients with COVID-19
Expert Review of Anti-infective Therapy·2024· 4 cited
The anti-COVID-19 drug Paxlovid crosses biological barriers of the placenta and brain in rats
npj Viruses·2024· 2 citedOpen Access
Pharmacokinetic analysis of placental transfer of ritonavir as a component of paxlovid using microdialysis in pregnant rats
Heliyon·2024· 3 citedOpen Access
Transporter modulation of molnupiravir and its metabolite β-D-N4-hydroxycytidine across the blood-brain barrier in a rat
Communications Medicine·2023· 6 citedOpen Access
Transfer and biotransformation of the COVID-19 prodrug molnupiravir and its metabolite β-D-N4-hydroxycytidine across the blood-placenta barrier
EBioMedicine·2023· 11 citedOpen Access
Behçet's disease-induced massive small intestinal bleeding successfully treated with adalimumab
Journal of Postgraduate Medicine·2023· 1 citedOpen Access
Biotransformation and brain distribution of the anti-COVID-19 drug molnupiravir and herb-drug pharmacokinetic interactions between the herbal extract Scutellaria formula-NRICM101
Journal of Pharmaceutical and Biomedical Analysis·2023· 12 citedOpen Access
Simultaneous toxicokinetic studies of aristolochic acid I and II and aristolactam I and II using a newly-developed microdialysis liquid chromatography-tandem mass spectrometry
Food and Chemical Toxicology·2023· 5 cited
Anti-Cancer Effects of Oxygen-Atom-Modified Derivatives of Wasabi Components on Human Leukemia Cells
International Journal of Molecular Sciences·2023· 3 citedOpen Access
Data from Positive Correlations of Oct-4 and Nanog in Oral Cancer Stem-Like Cells and High-Grade Oral Squamous Cell Carcinoma
2023Open Access
Supplementary Data from Positive Correlations of Oct-4 and Nanog in Oral Cancer Stem-Like Cells and High-Grade Oral Squamous Cell Carcinoma
2023Open Access
Data from Positive Correlations of Oct-4 and Nanog in Oral Cancer Stem-Like Cells and High-Grade Oral Squamous Cell Carcinoma
2023Open Access
Supplementary Data from Positive Correlations of Oct-4 and Nanog in Oral Cancer Stem-Like Cells and High-Grade Oral Squamous Cell Carcinoma
2023Open Access
page 1 of 24Next →

Frequent Co-authors

Lie-Chwen Lin(7), Shih‐Hwa Chiou(6), Hung‐Hai Ku(5), Der‐Cherng Tarng(4), Yu‐Tse Wu(4), Chian‐Shiu Chien(3), Lei-Chwen Lin(3), Ting-Yu Tseng(3), Yu-Jen Chen(3), Wen-Chuan Lee(3), Yin-Meng Tsai(2), Chao-Feng Chien(2), Yu‐Chih Chen(2), Shih‐Chieh Hung(2), Yuh-Lih Chang(2), Ching-Wei Chang(2), Li-Hui Li(2), Jen‐Shiu Chiang Chiau(2), Tsang-En Wang(2), Shou-Chuan Shih(2)